Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute Myelogenous Leukemia (AML) has exhibited a complete response following treatment in the CHM CORE-NK + Vactosertib Phase 1b trial. This achievement marks a cancer treatment innovation, highlighting immunotherapy progress and a significant cell therapy milestone. Chimeric Therapeutics, […]
In a dramatic turn of events, University of Pennsylvania President Elizabeth Magill has announced her resignation, following intense backlash over her response during a congressional hearing concerning remarks calling for the “genocide of Jews.” The school’s board of trustees confirmed this major development on Saturday. Magill, in a statement released by the board, expressed her […]
Kite, an arm of Gilead Sciences, has agreed to acquire Tmunity Therapeutics, a Philadelphia-based clinical-stage biotech company focused on next-generation CAR T-therapies and technologies, for an undisclosed amount. Under the agreement, Kite will acquire all the shares of Tmunity Therapeutics, which it already doesn’t own. The acquisition aligns with Kite’s current in-house cell therapy research […]
